Astrantus’s Illumina ILMN Stock Holding History

Astrantus’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,474	Closed	-$546K	–	235
2021 Q4	$546K	Buy	+1,474	New	+$558K	0.41%	105

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Astrantus's ILMN Position: Q1 2022 in Review

Astrantus sold out of Illumina (ILMN) in Q1 2022, closing a stake of 1,474 shares — an estimated $546K sold.

Astrantus first reported a position in ILMN in Q4 2021 and held it in 1 quarter. The position peaked at $546K in Q4 2021. 1,041 funds tracked by Wall St. Rank hold ILMN as of Q1 2022.

Astrantus reported no remaining Illumina position as of Q1 2022 after selling out during the quarter.
Astrantus sold 1,474 Illumina shares in Q1 2022, an estimated $546K.
Astrantus first reported a position in Illumina in Q4 2021 and held it in 1 quarter.
Astrantus's Illumina position peaked at $546K in Q4 2021.
1,041 funds tracked by Wall St. Rank held Illumina as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.